By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Statin > Lovastatin

Lovastatin

GMJ
Last updated: 01/06/2026 20:19
By
GMJ News Desk
Share
5 Min Read
SHARE
3 min read|643 words

Lovastatin Drug Profile

What is Lovastatin?

Lovastatin is a cholesterol-lowering medication that belongs to a class of drugs called statins (HMG-CoA reductase inhibitors). It is primarily prescribed to reduce elevated cholesterol levels and lower the risk of cardiovascular disease in patients with high cholesterol or other heart disease risk factors. Lovastatin was one of the first statins approved for clinical use and remains an important treatment option for managing dyslipidemia.

Uses

Lovastatin is approved for several cardiovascular-related conditions:

  • Primary hypercholesterolemia: Reducing elevated LDL (bad) cholesterol and total cholesterol levels in patients with high cholesterol
  • Mixed dyslipidemia: Treating patients with elevated cholesterol and triglycerides while helping to raise HDL (good) cholesterol
  • Primary prevention of coronary heart disease: Reducing cardiovascular risk in patients with elevated cholesterol and additional risk factors
  • Secondary prevention: Preventing future cardiovascular events in patients with existing coronary heart disease
  • Familial hypercholesterolemia: Managing inherited forms of high cholesterol, including in adolescent patients with heterozygous familial hypercholesterolemia

How it works

Lovastatin works by inhibiting HMG-CoA reductase, a key enzyme involved in cholesterol production in the liver. By blocking this enzyme, the medication reduces the liver’s ability to manufacture cholesterol, which forces the liver to remove more cholesterol from the bloodstream. This mechanism effectively lowers total cholesterol, LDL cholesterol, and triglycerides while modestly increasing beneficial HDL cholesterol levels.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Headache
  • Muscle aches or weakness
  • Abdominal pain or cramping
  • Nausea and digestive upset
  • Diarrhea or constipation
  • Dizziness
  • Skin rash
  • Sleep disturbances

Serious side effects requiring immediate medical attention:

  • Severe muscle pain, tenderness, or weakness (possible rhabdomyolysis)
  • Dark-colored urine or decreased urination
  • Yellowing of skin or eyes (jaundice)
  • Severe abdominal pain
  • Unexplained fatigue or weakness

Warnings and precautions

  • Liver function monitoring: Patients should have liver function tests performed before starting treatment and periodically during therapy, as statins can rarely cause liver damage
  • Muscle-related risks: The risk of muscle problems increases with higher doses, advanced age, kidney disease, and when combined with certain other medications
  • Pregnancy and breastfeeding: Lovastatin is contraindicated during pregnancy and breastfeeding, as cholesterol is essential for fetal development
  • Kidney disease: Patients with severe kidney impairment may require dose adjustments or alternative treatments
  • Alcohol consumption: Excessive alcohol use should be avoided as it may increase the risk of liver problems when combined with statins

Interactions

Lovastatin has several important drug interactions that can increase the risk of side effects:

  • Gemfibrozil and other fibrates: Significantly increases muscle toxicity risk and should generally be avoided
  • Cyclosporine: Increases lovastatin levels and muscle toxicity risk; dose adjustments required
  • Warfarin: May enhance anticoagulant effects, requiring more frequent INR monitoring
  • Erythromycin and clarithromycin: These antibiotics can increase lovastatin levels and toxicity risk
  • Antifungal medications (itraconazole, ketoconazole): Can dramatically increase lovastatin blood levels
  • Grapefruit juice: Contains compounds that can increase lovastatin levels; large amounts should be avoided
  • Niacin (high doses): May increase muscle toxicity risk when combined with statins
  • HIV protease inhibitors: Can significantly increase statin levels and require dose modifications

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosages for lovastatin range from 20 mg to 80 mg taken once daily with the evening meal, as cholesterol synthesis is highest at night. Most patients start with 20 mg daily, with doses adjusted based on cholesterol response and tolerability. The maximum recommended dose is 80 mg daily, though this higher dose is associated with increased risk of muscle-related side effects. Patients should take lovastatin with food to improve absorption and reduce stomach upset. Dosage adjustments may be necessary for patients with kidney disease or those taking interacting medications. All dosing decisions should be individualized and determined by a qualified healthcare provider based on the patient’s specific medical condition and response to treatment.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Lovastatin." GMJ News — Georgian Medical Journal, 1 June 2026. https://news.gmj.ge/drug/lovastatin-2/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Endometriosis Affects 10% of Women Yet Faces Chronic Under-recognition, BBC Investigation Reveals

BBC investigation reveals endometriosis affects 10% of women yet faces chronic under-recognition,…

Medical School Diversity Gains Not Translating to Diverse Physician Workforce

Despite medical schools successfully diversifying enrollment, these gains aren't translating to physician…

Maternity Staff Used Offensive Terms for Patients, BBC Investigation Reveals

BBC Panorama investigation reveals maternity staff at Nottingham University Hospitals NHS Trust…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Atorvastatin

By
GMJ News Desk
01/06/2026

Pravastatin

By
GMJ News Desk
01/06/2026

Simvastatin

By
GMJ News Desk
01/06/2026

Simvastatin

By
GMJ News Desk
01/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up